UCLA Department of Psychiatry
Psychiatry
Dr. Karen A. Miotto, MD
|
|
Give Review
Doctor Karen A. Miotto, MD practices Psychiatry. She attended University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is a top medical university. University of Colorado Denver School of Medicine is ranked 35 in research and 8 in primary care medicine She has 2 awards "Top Doctors:LA Area" and "Top Doctors:Southern California". Karen Miotto is a published doctor as well. She has 38 publications published. The latest was: Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. Karen Miotto accepts all Medicare patients.
Publications
- The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: A Double-Blind, Placebo-Controlled Laboratory Study.
- Varenicline, low dose naltrexone, and their Combination for heavy-drinking smokers: human laboratory findings.
- The effects of varenicline on Stress-induced and cue-induced craving for cigarettes.
- Subjective Response to Alcohol Among Alcohol-Dependent Individuals: Effects of the Mu-Opioid Receptor (OPRM1) Gene and Alcoholism Severity.
- Managing co-occurring substance use and pain Disorders.
- Comparisons of Analgesic Potency and Side Effects of Buprenorphine and Buprenorphine With Ultra-low-dose Naloxone.
- Widespread inhibition of neuroblastoma cells in the 13- to 17-day-old mouse embryo.
- Opioid pharmaceuticals and Addiction: the issues, and research directions seeking solutions.
- Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
- A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals.
- Psychiatric symptoms associated with ephedra use.
- Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
- Precipitated opioid withdrawal across acute physical Dependence induction methods.
- Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine Abusers.
- The effects and consequences of selected club Drugs.
- Naltrexone and dysphoria: fact or myth?
- Comparison of buprenorphine treatment for opioid Dependence in 3 settings.
- Pharmacogenetics of naltrexone in asian americans: a randomized placebo-Controlled laboratory study.
- A human laboratory study of the effects of quetiapine on subjective intoxication and Alcohol craving.
- Elevated plasma prolactin in abstinent methAmphetamine-dependent subjects.
- Withdrawal symptoms in abstinent methAmphetamine-dependent subjects.
- Naltrexone for the treatment of Alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.
- Urine and plasma pharmacokinetics of lofexidine after oral delivery in opiate-dependent patients.
- Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass s...
- A Phase 3 placebo-Controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
- Primary structure of the Neurospora crassa small subunit ribosomal RNA coding region.
- Molecular probe analysis of Shigella dysenteriae type 1 isolates from 1940 to 1987.
- Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine Abuse.
- Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal.
- Phylogenetic diversity and position of the genus Campylobacter.
- Screening for Addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool.
- Substance Abuse treatment for "hazardous users": an early intervention.
- Outpatient non-Opioid detoxification for Opioid withdrawal. Who is likely to benefit?
- Overdose, suicide attempts and death among a cohort of naltrexone-treated Opioid addicts.
- Regulation and distribution of members of the Opioid receptor family.
- Diagnosing addictive disease in chronic pain patients.
- Human Opioid receptors: chromosomal mapping and mRNA localization.
Schools
Univ Of Co Sch Of Med
Procedures Preformed
- Electroconvulsive Therapy (ECT)
- Family Psychotherapy
- Group Psychotherapy
- Psychiatric Medication Therapy
Conditions Treated
- Adjustment Disorder
- Alcoholism (Alcohol Dependence)
- Anxiety
- Bipolar Disorder
- View All
Doctors Specialties
- Addiction Psychiatry
- Psychiatry
Accepted Insurances
Awards
- Top Doctors:LA Area
- Top Doctors:Southern California
Education
-
UCLA Neuropsychiatric Hospital -
University of Colorado Denver School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1023041597 | |
| NPPES Provider LastName | MIOTTO | |
| NPPES Provider FirstName | KAREN | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 92.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023041597 |
| Last Name Of The Provider | MIOTTO |
| First Name Of The Provider | KAREN |
| View All |
Similar Doctors
|
|
Dr. Nancy A. McCarthy, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Gabor Vari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry R. Brickman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James E. Luzano, MD |
|
|
Dr. Larissa J. Mooney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore Pearlman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfonso Paredes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith W. Young, MD |
|
|
Dr. James A. Hirtle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret M. Haglund, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas P. Reeves, MD |
|
|
Dr. Shahe V. Soghomonian, MD |
|
|
Dr. Devin M. Stroman, MD |